Address 9735 Wilshire Blvd, Suite 216, Beverly Hills, CA 90212 (424) 652-6563 YouTube Instagram Twitter

Injectables Top-Rated injectable procedures in Beverly Hills

“Injectables” is a term that refers to various substances injected into the skin that restore a more youthful appearance to the face and body. Injectables are characterized into two main groups:

1. Fillers and biostimulatory molecules, which fill in/restore lost volume to various areas of the face and body

2. Neuromodulators (i.e. Botox/Dysport/Xoemin/Jeuveau), which soften overactive muscle movement that causes wrinkle

Dr. Kiripolsky is an expert Dermatologist in Beverly Hills

Dr. Kiripolsky has been described as an artist, in that she combines treatments to achieve the best results; individualized to each patient in the most comfortable manner possible. She evaluates the entire body area needing rejuvenation from all angles. Her Beverly Hills dermatology office uses the latest, most advanced injection techniques to restore a more youthful, natural, rejuvenated appearance to her patients. She uses a variety of injectables, often combining more than one to achieve the most natural, long-lasting results. See below for some of the many injectables that our Beverly Hills dermatology clinic is proud to offer to our patients. If you have any questions about any dermatology procedures, contact us today or visit our Beverly Hills dermatology office. 

Injectable Fillers and Biostimulatory Molecules in Beverly Hills

Dr. Kiripolsky is a board-certified dermatologist and fellow-trained cosmetic and laser surgeon, highly-regarded for her expertise in Beverly Hills for treating stubborn skin conditions such as acne, rosacea, melasma and other types of skin discoloration, eczema, sun damage, and additional chronic skin diseases. Dr. Kiripolsky is also an author, speaker, researcher, and teacher. Visit our Dermatology office in Beverly Hills and see how Dr. Kiripolsky can help you with various dermatology procedures.

      RADIESSE 

Injectable Neuromodulators Procedures in Beverly Hills

Dr. Monika Kiripolsky of MKMD offers patients of all ages the latest techniques using cutting-edge technology to treat a wide range of cosmetic dermatology conditions including acne, acne scarring, uneven skin color (including melasma and post-inflammatory hyperpigmentation), redness (broken capillaries, rosacea, and poikiloderma), aging skin, scars, unwanted/excess fat, and overall skin improvement. Her goal is for you to love your skin so much that you don’t feel as if you need to wear makeup or use filters in any of your selfies. Visit our dermatology clinic in Beverly Hills to see how Dr. Kiripolsky can help alleviate your chronic skin conditions. 

Juvederm Dermal FillerDermatology Services in Beverly Hills

What is Juvederm?
Juvederm is an FDA-approved dermal filler that is injected just below the surface of the skin to restore volume, smooth wrinkles, and create an overall more youthful appearance. Juvederm lasts about 6-12 months. 

Side Effects from Juvederm
Some mild swelling and bruising is to be expected from the injected area. There are very little side effects to hyaluronic acid fillers. 

VolumaDermatology Services in Beverly Hills

What is Voluma?
Voluma is one of the only FDA-approved hyaluronic acid fillers that instantly adds volume to the cheek area. It is composed of shorter chains of hyaluronic acid with many “cross links.” 

Where can Voluma be Injected?
Voluma is most commonly used and has been FDA-approved for injection to the mid-face and lift sunken cheeks. It is also usually used for contouring to the areas such as the jawline and temples.

VollureDermatology Services in Beverly Hills

What is Vollure?
Vollure is an FDA-approved dermal filler composed of hyaluronic acid that is specifically designed for the nasolabial folds and “parenthesis” around the mouth. It is the longest lasting filler for the mid-face (up to 18 months). It uses Vycross Technology, which is a unique cross-linking of both high and low weight hyaluronic acid molecules.

What area of the face can Vollure be used?
It is best used to provide support and subtle augmentation to facial wrinkles and nasolabial folds. The best candidates for this injectable are patients with mild to moderate nasolabial folds and marionette lines.

VolbellaDermatology Services in Beverly Hills

What is Volbella?
Volbella is an FDA-approved “gel implant” that was originally geared towards injection into lips to restore lost volume. It is now also used to improve the appearance of darkness or hollowness under the eyes by temporarily adding volume or fullness.

Where is Volbella injected?
Volbella was released initially for subtle lip augmentation and texture improvement. It is also used in other areas of the face to smooth out subtle texture concerns. Volbella has been used to improve fine acne scarring and to smooth and fill out the horizontal lines found on the neck area.

Patient Testimonials

Restylane® LyftDermatology Services in Beverly Hills

What is Restylane® Lyft?
Restylane Lyft is an FDA-approved, hyaluronic acid filler that can be administered in the backs of the hands as wells as into various areas of the face for younger looking skin.

Where can Restylane® Lyft be injected?
Restylane Lyft can be injected in many areas of the face. It is commonly used for correction of moderate to severe facial wrinkles and folds including the nasolabial folds, marionette lines, vertical lip lines, and corners of the mouth. It is also sometimes used to restore volume in the cheeks.

Restylane-LDermatology Services in Beverly Hills

What is Restylane-L?
Restylane is an FDA-approved dermal filler that adds volume and fullness and corects moderate to severe facial wrinkles and nasolabial folds (the lines that extend from the corners of our nose to the corners of our mouth). It may also be used for lip enhancment as well as off-label for hollowness under the eyes (in the “tear troughs”).

Where can Restylane-L be injected?
Restylane-L can be effectively used in many areas of the face including the nasolabial folds, marionette lines, vertical lip lines, and corners of the mouth. It was also FDA-approved for lip augmentation.

Restylane Refyne & DefyneDermatology Services in Beverly Hills

What is Restylane Refyne & Defyne?
Restylane Refyne & Defyne are FDA-approved hyaluronic fillers used to soften laugh lines (nasolabial folds and marionette lines). It is a newer filler that was formulated for maximal movement with the surrounding skin, allowing people to maintain a natural look while making various facial expressions. Restylane Defyne is a smooth gel that is used for filling deeper wrinkles while Restylane Refyne is a lighter product used for filling shallower facial wrinkles.

Where is Restylane Refyne & Defyne used?
Restylane Defyne is used for deep wrinkes to provide structure, support, and volume that have been lost over time. It is often used for deep lines around the nasolabial folds but can also be used for marionette folds, the cheeks, and jawline.

Restylane-SilkDermatology Services in Beverly Hills

What is Restylane-Silk?
Restylane Silk is an FDA-approved hyaluronic acid specifically designed for lip augmentation as well as smoothing wrinkles around the mouth (“smoker’s lines”)

Where can Restylane-Silk be injected?
Restylane-Silk is most commonly used to treat wrinkles around the mouth and for lip augmentation. It can also be used to correct forehead lines, crow’s feet, and horizontal neck lines.

Monika Kiripolsky | Beverly Hills Dermatologist and Cosmetic Surgeon

Certified Beverly Hills Dermatologist with 20 years of experience conducting various skin improving procedures.

Dr. Kiripolsky has performed research on a range of cosmetic surgery, dermatology, and laser treatments In Beverly Hills.

  • Anti-aging
  • Cosmetic surgery
  • Laser treatments
  • Autologous fat transfer
  • Sclerotherapy (leg vein surgery)
  • Endovenous laser ablation (advanced leg vein surgery)
  • Liposculpture / Liposuction
  • Deep chemical peels
  • Advanced facial contouring with fillers
  • Botox, Dysport, Xeomin
  • Restylane, Restylane Lyft, Restylane Refyne, Restylane Defyne, Juvederm, Voluma, Vollure, Volbella
  • Sculptra, Radiesse

Restylane KysseDermatology Services in Beverly Hills

What is Restylane Kysse?
Restylane Kysse is an FDA-approved lip filler used to add volume, enhance natural lip color, and smooth upper lip lines.

How long does Restylane Kysse last?
Restylane Kysse was approved to last for 48-52 weeks. However, because the lips are a very active area (a lot of movement), the filler can be expected to last anywhere between 6-12 months. A touch up is recommended for optimal results.

Restylane ContourDermatology Services in Beverly Hills

What is Restylane® Contour?
Restylane Contour is the newest Restylane hyaluronic acid filler. It is FDA-approved and specifically created for cheek augmentation and correction of midface contour deficiencies in adults over the age of 21.

How long does Restylane® Contour last?
Restylane Contour can last for up to 48 weeks. For optimal results, it may take more than one syringe depending on desired result. Occasional touch-up treatments will ultimately yield the best long-term outcome.

Radiesse LyftDermatology Services in Beverly Hills

Before and After Photo of Woman's Wrist

What is Radiesse®?
Radiesse is an FDA-approved combination of a dermal filler as well as a biostimulatory molecule, which is used to smooth moderate to severe facial wrinkles and nasolabial folds. It is also used to correct volume loss in the back of the hands.

Where is Radiesse® usually injected?
Ideally, Radiesse is injected to correct moderate to severe facial wrinkles, lines, and folds and to improve the appearance of the back of the hands.

BeloteroDermatology Services in Beverly Hills

What is Belotero?
Belotero is a prescription injection approved to smooth out and add volume to moderate to severe nasolabial folds temporarily.

What areas of the face is Belotero used?
Belotero is used to effectively and safely erase fine lines on the face. Unlike other fillers, Belotero is strategically placed more superficially to fill in fine lines.

SculptraDermatology Services in Beverly Hills

What is Sculptra?
Sculptra is a biostimulatory molecule, meaning that it causes your own body to produce more collagen. Multiple treatment sessions are typically suggested to “layer” the product, which subtly and gradually restores facial volume.

How long does Sculptra last?
Sculptra is approved to last for up to 2 years, but clinical studies have shown some patients may experience up to 36 months of result.

Where can Sculptra be injected?
Sculptra is used to restore volume in areas of the face that have sunken over time, most commonly the temples, jawline, cheeks, and deep facial folds such as the nasolabial folds and marionette lines.

What are some of the side effects?
As with any injectable filler, some may experience some mild swelling or bruising. These temporary side effects can be minimized with proper injecting technique.

Your questions, answered.

Dr. Kiripolsky provides expert answers to your questions about skin care, dermatology, cosmetic procedures, and cosmetic surgery on RealSelf.com.
(RealSelf links below open in new windows.)

BotoxDermatology Services in Beverly Hills

What is Botox?
Botox is the first FDA-approved botulinum toxin injectable, which is made by the bacterium Clostridium botulinum. Botox injections work by blocking signals from the nerves to the muscles, therefore weakening these muscles so that they do not contract.

Where can Botox be injected?
Botox is used to temporarily improve the appearance of frown lines, crow’s feet, and forehead lines. It can also be used to treat conditions such as chronic migraines, lazy eye, TMJ pain, and hyperhidrosis (excessive underarm sweating).

JeuveauDermatology Services in Beverly Hills

What is Jeuveau?
Jeuveau is FDA-approved and is injected into the muscles to temporarily smooth and improve the appearance of moderate to severe frown lines between the glabellar lines (eyebrows).

Where can Jeuveau be injected?
Similar to Botox, Jeuveau can be injected to improve the appearance of forehead lines, crow’s feet, bunny lines of the nose, wrinkles around the mouth, and neck bands (platysmal bands).

XeominDermatology Services in Beverly Hills

What is Xeomin?
Xeomin is another neurotoxin that blocks the release of chemicals that cause muscle contractions which in time create frown lines. It is used to soften these lines and create a more youthful look.® usually injected?

Where can Xeomin be injected?
Xeomin can be used to temporarily improve the appearance of frown lines, crow’s feet, and forehead lines. It can also be used to treat conditions such as chronic migraines, lazy eye, TMJ pain, and hyperhidrosis (excessive underarm sweating).

DysportDermatology Services in Beverly Hills

What is Dysport?
Dysport is another type of botulinum toxin injection that is FDA-approved to improve the appearance of wrinkles and unwanted facial lines. It works similarly with Botox in that it blocks the communication between nerve endings and their surrounding muscles, therefore weakening the muscles in that area.

Where can Dysport be injected?
Similar with Botox, Dysport can be used to temporarily improve the appearance of frown lines, crow’s feet, and forehead lines. It can also be used to treat conditions such as chronic migraines, lazy eye, TMJ pain, and hyperhidrosis (excessive underarm sweating).

Dr. Kiripolsky’s Many Accolades

Cassileth Plastic Surgery and Skin Care, Beverly Hills, CA 11/2016 – present
  • Specializing in dermatology, dermatologic surgery, laser procedures, and cosmetic surgery
  • Performing varicose vein treatment/sclerotherapy, autologous fat transfer, and liposculpture/liposuction
MKMD/Monika G Kiripolsky, MD Inc,, Beverly Hills, CA 11/2014 – 11/2016
  • Specializing in dermatology, dermatologic surgery, laser procedures, and cosmetic surgery
  • Performing varicose vein treatment/sclerotherapy, autologous fat transfer, and liposculpture/liposuction
Obagi Skin Health Institute, Beverly Hills, Laguna Beach, Pasadena CA 10/2012 – 11/2014
  • Specialized in cosmetic dermatology, lasers, chemical peels, leg vein treatments, liposculpture/liposuction, and advanced use of fillers.
  • ZO Skin Health & ZO Medical Physician Faculty Member
True Beauty: San Diego Skin and Laser, Carlsbad, CA 9/2010– 2012
  • Specialized in dermatology, dermatologic surgery, laser procedures, and cosmetic surgery
  • Also performed varicose vein treatment/sclerotherapy, autologous fat transfer, and liposculpture/liposuction
GBK Cosmetic Laser Dermatology, San Diego, CA 8/2009 – 8/2010
  • Completed 1-year fellowship in laser & cosmetic surgery; program accredited by the American Academy of Cosmetic Surgery
  • Served as the elected Director of Research for the practice, which entailed overseeing each step of the approximately 35 clinical studies being conducted
North Coast Dermatology, Inc., Encinitas, CA 4/2009 – 7/2009
  • Diagnosed/treated dermatologic diseases, performed surgical & cosmetic procedures and supervised physician assistants
Dermatologist Medical Group of North County, Inc., La Jolla, CA 9/2008 – 2/2009
  • Diagnosed and treated dermatologic conditions, read histopathology, and performed surgical and cosmetic procedures
University of Illinois, Chicago, IL 7/2005 –7/2008
  • Completed 3-year residency in the Department of Dermatology; became board-certified in dermatology in 2008
University of California – Irvine, City of Orange, CA 2004 – 2005
  • Completed an internship through the Internal Medicine Department
Vanderbilt University School of Medicine, Nashville, TN 1999 – 2004
  • Earned an M.D. in 5/04
University of California, Los Angeles, Los Angeles, CA 1995 – 1999
  • Bachelor of Science – Graduated from the UCLA Honors College
  • Majored in Psychobiology with Specialization in Business and Economics
  • Earned Magna Cum Laude distinction
  • Massaki AB, Kiripolsky MG, Detwiler SP, Goldman MP. “Endoluminal laser delivery mode and wavelength effects on varicose veins in an ex vivo model.” Lasers Surg Med. 45(2): 123-9, 2013.
  • Sundaram, H and Kiripolsky, M. “Nonsurgical rejuvenation of the upper eyelid and brow.” Clin Plast Surg. 40(1): 55-76, 2013.
  • Kiripolsky MG, Peterson JD, Goldman MP. “Safety and efficacy of administering abobotulinumtoxinA through a single injection point when treating lateral periocular rhytides.” J Cosmetic Dermatol. 10(3): 232-4, 2011.  
  • Kiripolsky MG, Peterson JD, Goldman MP. “A two-phase, retrospective analysis evaluating efficacy and patient satisfaction with  AbobotulinumtoxinA when used to treat dynamic facial rhytides.” Dermatol Surg. 37(10): 1443-7, 2011.  
  • Peterson JD, Palm M, Kiripolsky MG, Guiha IC, Goldman MP. “Evaluation of the impact of fractional laser with radiofrequency and a fractionated radiofrequency on the improvement of acne scars.” Dermatol Surg. 37(9): 1260-7, 2011.
  • Peterson JD, Kiripolsky MG, Goldman MP. “Methicillin-resistant Staphlococcus aureussuperinfection delaying the diagnosis of atypical mycobacteria infection: Report of a case.” J Cosmetic Dermatol. 24: 170-3, 2011.  
  • Kiripolsky MG.  “More on ethanolamine oleate as a vascular sclerosant.” Dermatol Surg. 36(7): 1153-4, 2010.
  • Kiripolsky MG. “More on hypertrichosis after sclerotherapy.” Dermatol Surg. 36: 1066-7, 2010.
  • Kiripolsky MG, Goldman MP; Editors: Goldman MP, Bergan JJ, and Geux JJ. 2010. Chapter 4: Pathophysiology of Telangiectasias. Sclerotherapy: Treatment of Varicose and Telangiectatic Leg Veins. 5th Ed. Mosby Elsevier, Philadelphia.
  • Kiripolsky MG, Goldman MP; Editors: Goldman MP, Bergan JJ, and Geux JJ. 2010. Chapter 8: Complications of Sclerotherapy. Sclerotherapy: Treatment of Varicose and Telangiectatic Leg Veins. 5th Ed. Mosby Elsevier, Philadelphia.
  • Kiripolsky MG, Goldman MP; Editors: Goldman MP, Bergan JJ, and Geux JJ. 2010. Chapter 13: Treatment of Leg Telangiectasias with Laser and High-Intensity Pulsed Light. Sclerotherapy: Treatment of Varicose and Telangiectatic Leg Veins. 5th Ed. Mosby Elsevier, Philadelphia.
  • Kiripolsky MG, Goldman MP; Editors: Goldman MP, Bergan JJ, and Geux JJ. 2010. Chapter 15: Setting up a Sclerotherapy Practice. Sclerotherapy: Treatment of Varicose and Telangiectatic Leg Veins. 5th Ed. Mosby Elsevier, Philadelphia.
  • Kiripolsky MG, Peterson JD, Goldman MP. “Retrospective analysis to assess efficacy and patient satisfaction of Dysport compared to Botox in the treatment of dynamic rhytides.” (abstract and live presentation) Cosmetic Surgery Forum 12/2009.
  • Hernandez C, Kiripolsky MG. “Persistent lower extremity ulcers after a pedicure.” J of Gen Internal Med. (in press: MS# 6232).
  • Hernandez C, Worobec S, Gaitonde S, Kiripolsky MG, Aquino, K. “Progression of undiagnosed cutaneous T-cell lymphoma during efalizumab therapy.” Archives of Dermatol. 145(1): 92-3, 2009.
  • Kiripolsky MG, Peterson JD, Cohen JL, Gold MH, Goldman MP. “Benefits of using a hydroquinone/tretinoin skin care system in patients undergoing intense pulse light therapy for photorejuvenation of the decolletage: a randomized-controlled study.” American Society for Laser Medicine and Surgery Annual Meeting – accepted 12/2009 as an abstract and ePoster presentation.
  • Peterson JD, Palm MD, Kiripolsky MG, Goldman MP. “Evaluation of the impact of fractional laser (Matrix IR) and fractionated radiofrequency (Matrix RF) on the improvement of acne scars.” American Society for Laser Medicine & Surgery Annual Meeting – accepted abstract 12/2009 & ePoster presentation.
  • Kiripolsky MG, Zic JA, Nelson RA. “Basal cell carcinoma treated with topical bexarotene 1% gel: an open label controlled study.” J of the Amer Acad of Dermatol. 50(3): 122, 2004.
  • Lichon VC, Kiripolsky MG, Hill CH. “Long-term dapsone use and the development of Non-Hodgkin’s Lymphoma in two patients with Hansen’s Disease: Coincidence or valid link?” Archives of Dermatol. (submitted).
  • Sams, HH, Kiripolsky MG, Bhat, LS, Stricklin GP. “Porphyria cutanea tarda, hepatitis C, and hemochromatosis: A case report and review of the literature.” Cutis. 73(3): 188-90, 2004.
  • Zic JA, Kiripolsky MG, Hamilton K, Greer JP. 2004. Chapter 94: Cutaneous T-Cell Lymphoma: Mycosis Fungoides and Sezary Syndrome. Wintrobe’s Clinical Hematology. 11th Ed.. Lippincott Williams & Wilkins, Philadelphia: 2485-520.
  • Sams HH, Kiripolsky MG, Boyd AS, King LE Jr. “Crohn’s disease of the penis masquerading as pyoderma gangrenosum; a case report and review of the literature.”  Cutis. 72(6): 432-7, 2003.
  • Kiripolsky MG. “.” The Aesthetics Show – Annual Meeting, 7/2016 [lecture/presentation; Las Vegas, NV].
  • Kiripolsky MG. “Growth Factors: Essential Skin Care to Pre-, Peri-, and Post-Procedure Protocols.” The Aesthetics Show – Annual Meeting, 7/2016 [lecture/presentation; Las Vegas, NV].
  • Kiripolsky MG. “Optimizing Dermal Filler Hand Rejuvenation.” The Aesthetics Show – Annual Meeting, 7/2016 [lecture/presentation; Las Vegas, NV].
  • Kiripolsky MG. “Growth Factors: Fact & Fiction.” The Aesthetics Show – Annual Meeting, 7/2016 [lecture/presentation; Las Vegas, NV].
  • Kiripolsky MG. “Next-Generation Anti-Aging Skincare.” The Aesthetics Show – Annual Meeting, 7/2015 [lecture/presentation; Las Vegas, NV].
  • Kiripolsky MG. “Growth Factors: Everything You Need to Know From Essential Skin Care to Post Procedure Protocols.” The Aesthetics Show – Annual Meeting, 7/2015 [lecture/presentation; Las Vegas, NV].
  • Kiripolsky MG. “A Systematic Approach to Skin Resurfacing.” Dallas Cosmetic and Rhinoplasty Symposium – 31st Annual Scientific Meeting, 3/2014 [lecture/presentation; Dallas, TX].
  • Kiripolsky MG. “Innovations in Skin Health Science.” ZO Skin Health, Inc. Skin Care Practitioner Seminar, 12/2013 [lecture/presentation; Orlando, FL].
  • Kiripolsky MG. “Expanded Conceptsand Principles of Skin Health Science”. ZO Skin Health, Inc. Skin Care Practitioner Seminar, 8/2013 [lecture/presentation; Chicago, IL].
  • Kiripolsky MG. “Rejuvenation of the Decolletage.” Vegas Cosmetic Surgery & Aesthetic Dermatology Conference – 9th Annual Scientific Meeting, 6/2013 [lecture/presentation; Las Vegas, NV].
  • Kiripolsky MG. “Topical application of the secretion of Cryptomphalus Aspersa for the reduction in signs of facial photoaging.”  International Pharmaceutica Cantabria – Annual Meeting, 6/2011 [lecture/presentation; Santander, Spain].
  • Kiripolsky MG. “The Role of Growth Factors in Skin Care.”  The Aesthetics Show – Annual Meeting, 6/2011 [lecture/presentation; Las Vegas, NV].
  • Kiripolsky MG. “Peri-Procedure Modalities.”  Society of Dermatology Skin Care Specialists – 9th Annual Scientific Meeting, 2/2011 [lecture/presentation; New Orleans, LA].
  • Kiripolsky MG, Peterson JD, Goldman MP. “A two-phase, retrospective analysis of patient satisfaction with abobotulinumtoxinA in the treatment of dynamic rhytides.”  American Academy of Cosmetic Surgery – 27th Annual Scientific Meeting, 1/2011 [presentation & abstract publication; Scottsdale, AZ].
  • Kiripolsky MG, Goldman MP, Detwiler S. “A comparison of endovenous laser delivery mode and wavelength on varicose veins.”  American College of Phlebology – 24th Annual Congress Meeting, 11/2010 [presentation and abstract publication; Orlando, FL].
  • Kiripolsky MG, Peterson JD, Goldman MP. “A two-phase retrospective analysis evaluating efficacy and patient satisfaction with Abobotulinumtoxin A when used to treat dynamic rhytides.” American Society for Dermatologic Surgery/American Society of Cosmetic Dermatology & Aesthetic Surgery Annual Meeting, 10/2010. [presentation and abstract publication; Chicago, IL].
  • Kiripolsky MG, Krunic AL.“Metastatic Crohn’s-like colitis in a patient with Hermansky-Pudlak Syndrome” [Presented at 65th Annual American Academy of Dermatology Convention 2/2007; Washington, DC].
  • Kiripolsky MG, Zic J, Nelson, R. “Nodular basal cell carcinoma treated with topical bexarotene 1% gel: An open label controlled study.” [Presented at 62nd Annual American Academy of Dermatology Convention 2/2004; New Orleans, LA].
  • Kiripolsky MG, Zic J. “Laboratory and clinical variables associated with response and survival in 50 patients with refractory CTCL treated with photopheresis.” [Presented at 61st Annual American Academy of Dermatology Convention 2/2003; San Francisco, CA].
  • A Phase 3, Multicenter, Open-Label Extension Study to Assess the Long-Term Safety of Repeat Administrations of Reloxin® in the Treatment of Glabellar Lines
  • A Phase III, Multi-Center, Long-Term, Repeat-Treatment, Open-Label, Single-Arm Trial to Demonstrate the Safety of Repeat Treatment with PurTox® for the Treatment of Glabellar Rhytides
  • A Side-by-Side Two-Hand Comparison Pilot Study of Fat Transplantation Harvested via Traditional Syringe Aspiration versus Water Jet Aspiration
  • A Multi-center, Randomized, Double-Masked, Placebo-Controlled, Dose-Ranging Study of the Safety and Efficacy of Subcutaneous Injections of a Novel β2-Adrenergic Receptor Agonist Compared with Placebo for the Reduction of Abdominal Subcutaneous Adiposity
  • Treatment of Cellulite and Circumferential Fat Reduction with a 15 Watt Device Combining 650nm and 915nm Laser Emission with Vacuum and Mechanical Massage to Diminish the Appearance of Thigh Cellulite – Evaluation of the Efficacy of Sequential Treatments with a 15 Watt Device Combining 650nm and 915nm Laser Emission with Vacuum and Mechanical Massage in Pre- and Post-Lipoplasty Procedures
  • A Side-by-Side Comparison of the VelaShapeII and a Cold Laser Device for the Reduction of Thigh, Hip, and Waist Circumference
  • A Split-Face Study to Evaluate the Efficacy & Tolerability of Combination Therapy with Azaleic Acid Gel & Intense Pulse Light Therapy in the Treatment of Mild to Moderate Rosacea
  • A Single-Center, Randomized, Split-Face Study to Compare the Efficacy of Photodynamic Therapy with Metvixia Using Blue versus Red Light Sources for Treatment of Facial Acne
  • A Split-Face Study Investigating A Novel Topical Photosensitizing Preparation Combined with Multiple Laser and Light Sources for Photorejuvination
  • A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Tolerability of a Topical Glutathione Patch For the Treatment of Moderate Acne Vulgaris
  • Treatment of Reticular and Telangiectatic Leg Veins: Double-Blind, Prospective Comparative Trial Between Polidocanol and Hypertonic Saline
  • A Clinical Study Evaluating Efficacy and Patient Satisfaction with Use of a Topical Regimen Containing Hydroquinone, Tretinoin, and Salicylic Acid compared to a Topical Placebo Regimen in Individuals Undergoing Botulinum Toxin Injections as well as Injectable Hyaluronic Acid Filler to Nasolabial Folds
  • A Phase III, Randomized, Side-by-Side Comparative Study of the 1064-nm Nd:YAG Laser to the 1320-nm Nd:YAG Laser for the Treatment of Onychomycosis
  • A Phase IV, Randomized, Split-Face Study Comparing the Order of Administration of the Lumenis UltraPulse Active FX and Deep Fx CO2 Laser for the Treatment of Rhytides, Photo-Damage, & Scarring
  • A Split-Face Study Investigating Acne Scar Reduction with a Fractionated Radiofrequency Device Versus a Fractionated, Multiplex 1320nm and 1440nm Nd:YAG Laser
  • A Study Evaluating the Efficacy of an Integrated Vacuum-Assisted Diode Device For Laser Hair Reduction in Skin Types IV-VI
  • Micro-Pulsed 1064-nm Nd:YAG Laser versus Long-Pulsed 1064-nm Nd:YAG Laser Treatment for Hair Reduction, Pain Assessment, and Time Efficiency in Patients with Axillary Hypertrichosis
  • A Randomized, Side-by-Side, Placebo-Controlled Study Comparing Varying Settings of a Fractionated CO2 Laser in the Treatment of Striae
  • Investigation of a Novel Post-Laser Resurfacing Skin Care Regimen Consisting of Both Ointment and Cream Formulations
  • A Clinical Study Evaluating the Added Benefit, Safety, and Patient Satisfaction of Injectable Poly-l-lactic acid, Sculptra, Combined with Intense Pulsed Light for Chest Rejuvenation
  • Overall Fellowship Recipient 2003 – Funded dermatology rotation at Hospital San Pau, Barcelona, Spain – 6/2003
  • Voting Member – Represented Vanderbilt Medical School at AMSA’s 51st Ann Convention – 3/2001
Contributing Editor

 Journal of Dermatologic Surgery& Journal of Cosmetic Dermatology        2009 – 2010

  • Review, suggest revisions for, and publish commentaries on manuscripts submitted for publication consideration.
Instructor, Mastery of Lasers Course

American Society of Dermatologic Surgery; La Jolla, CA 11/2009

  • Instructed attendees via a live demonstration with question and answer session on the eMatrix (infrared + radiofrequency) laser
Volunteer for Skin Cancer Screening Day

American Academy of Dermatology, La Jolla, CA 2008 – 2009

  • Performed full-body skin exams on members of the community and made recommendations regarding biopsy of skin lesions suspicious for skin cancer
Voting Member, Resident Selection Committee

UIC, Department of Dermatology, Chicago, IL 2005 – 2006

  • Selected as one of three dermatology residents to join faculty to screen applications and select candidates for interviews
Chairman of Medical Center’s “Cadaver Ball”

Vanderbilt University, Nashville, TN 2004

  • Organized publicity, planning, and entertainment for this annual 800+ person gala
Visiting Student Extern                                                         

Hospital San Pau – Servicio de Dermatologia, Barcelona, Spain 2003

  • Participated in general, pediatric and cutaneous lymphoma clinics, and in inpatient dermatology consults (in Spanish)
  • Presented research at “XXXI Congreso Nacional de Dermatologia y Venereologia” in Bilbao, Spain
Sub-Investigator and Co-Author, Medical Scholars Program

VUMC, Division of Dermatology, Nashville, TN 2002 – 2003

  • Served as sub-investigator of Phase 2 study using bexarotine 1% gel for treatment of basal cell carcinoma
  • Co-authored Wintrobe’s Textbook of Hematology chapter: “Cutaneous T-cell Lymphoma: Mycosis Fungoides and Sézary Syndrome”
  • Formulated Vanderbilt ALCL patient database and evaluated trends in disease diagnosis, prognosis, and treatment
Dermatology Interest Group Leader, Student Advisory Committee

Vanderbilt University, Nashville, TN               2002 – 2003

  • Designed sessions led by dermatology attendings and residents to encourage medical students interested in dermatology
  • Designed a website for the organization (www.mc.vanderbilt.edu/medschool/derminterest/DIGWebSite.html)
  • Promoted mentoring relationships between dermatology faculty and students
Admission Interview Student Representative 2002 – 2003
  • Presented daily interactive sessions to interviewing applicants on curriculum, student life and joint-degree programs
  • Coordinated presentations with faculty representative to focus on the strengths of Vanderbilt’s medical training program
Contributing Author, The Reporter (Vanderbilt Medical Center’s Newspaper) 2002 – 2004
  • Composed weekly articles highlighting accomplishments of Vanderbilt Medical Center faculty & students
Chairman of Social Events, Committee of Class Officers 2000 – 2003
  • Planned inter/intra-class events to ensure extracurricular interests of medical students were supported by administration
  • Met regularly with Deans, Chancellor and fellow officers to integrate social and philanthropic events into the curriculum
Chief Editor, The Paddle and The Oar 2000 – 2002
  • Organized guide to Nashville and to 1st & 2nd year courses for incoming medical students
  • Contributed to guide of clinical rotation requirements for rising 3rd year medical students
Chairman, “Second Look Weekend” (1st Annual) 2001
  • Planned and implemented a 2-day informative and social event for recruitment of the top 75 medical school candidates
Course Leader, Problem Solving Elective 2000 – 2001
  • Led problem-based learning course for fello w medical students through presentation of clinical cases with associated labs, histopathology, gross organ specimens, and imaging studies
Acting Student Member, Medical School Admissions Committee 2000 – 2001
  • Selected by faculty and students to screen (approx 8 h/wk) and present all applicants at weekly committee meetings
  • Voted in all committee deliberations, reflecting the collective opinion of VMS’s student body
Chairman & Editor, Co-op Note-taking Service 1999 – 2000
  • Led classmates in collective documentation of all 1st & 2nd year med student lectures
Participant, Introduction to Biomedical Research (Dermatology) 2000

Veterans Affairs Hospital, Nashville, TN

  • Entered and analyzed data on the use of extracorporeal photopheresis to treat cutaneous T-cell lymphoma (Dr. J. Zic)
  • Created Excel spreadsheet programs to chart data; presented graphical findings to peers